Editor Conflict of Interest Disclosures

A PDF of the Editors' conflict of interest disclosure information is available for download here.

Leadership: Tesaro

Consulting or Advisory Role: ZIOPHARM Oncology, Conatus

Honoraria: Pfizer

Consulting or Advisory Role: UnitedHealthcare

Research Funding: Novartis

Honoraria: Pfizer, Genentech/Roche

Speakers' Bureau: Pfizer

No conflicts to report

Honoraria: Prime Oncology, Elsevier, Itamar Medical

Consulting or Advisory Role: Monteris Medical, Incyte, AstraZeneca, Bristol-Myers Squibb, Abbvie

Research Funding: Novartis, TRACON Pharma, Novocure, Spectrum Pharmaceuticals, Lilly/ImClone, Boehringer Ingelheim

No conflicts to report

Stock & Other Ownership Interests: Aerocrine

Honoraria: Lilly

Consulting or Advisory Role: Aerocrine, Celgene, Thermo Fisher Scientific, Biodesix

Travel, Accomodations, Expenses: Lilly, Celgene

Consulting or Advisory Role: INC Research and Cyt RX, Marathon Pharma, Morphotek

No conflicts to report

No conflicts to report

Leadership: Artelo

Stock & Other Ownership InterestsPRM Pharmaceutical, Artelo Pharma, Madorra

Consulting or Advisory Role: Clinical Oncology Advisory Group, Bristol-Myers Squibb, Apotex, Physician Resource Management, OnQ, Cascadian Therapeutics, Varian Medical Systems, Mylan, Tersera, BeyondSpring Pharmaceuticals

Research Funding: Amgen, BeyondSpring Pharmaceuticals

Honoraria: AstraZeneca, Bristol-Myers Squibb, Biodesix, Merck, Pfizer, Roche/Genentech, Trovagene, Lilly

Consulting or Advisory Role: AstraZeneca, Bristol-Myers Squibb, Biodesix, Merck, Pfizer, Roche/Genentech, Trovagene, Lilly

Research Funding: AstraZeneca, Bristol-Myers Squibb, Corvus Pharmaceuticals, Five Prime Therapeutics, Biodesix, Roche/Genentech, Lilly, Merck, Pfizer

Employment: WellVia

Leadership: WellVia

Stock & Other Ownership Interests: SirenMD, AVIA, EpicMD

Honoraria: WellVia, EpicMD, SirenMD

Travel, Accommodations, Expenses: WellVia, SirenMD, EpicMD

No conflicts to report

Employment: Flatiron Health

Patents, Royalties, & Other Intellectual Property: Patents pending relating to inventions as employee of NCCN

Other Relationships: National Comprehensive Cancer Network

No conflicts to report

No conflicts to report

Employment: Texas Oncology, University of Texas Southwestern Medical Center - Simmons Cancer

Leadership: Texas Oncology, Parkland Health System

Stock & Other Ownership Interests: Amgen, Medfusion, Merck, Pfizer

Research Funding: US Oncology

Other Relationships: Mary Crowley Research Center (Dallas, Texas), American Society of Clinical Oncology, Methodist Health System (Dallas, Texas)

Consulting or Advisory Role: Bayer, MDx, Genomic Health, Janssen Pharmaceuticals, Dendreon and Ferring

Research Funding: National Institutes of Health, University of Colorado Cancer Center

Employment (spouse): Dendreon

No conflicts to report

Leadership: Blueprint Medicines

Stock & Other Ownership Interests: Blueprint Medicines, G1 Therapeutics, Bessor Pharma, Caris Life Sciences, Champions Oncology, N-of-One

Consulting or Advisory Role: Bayer, Pfizer, Novartis, Lilly, EMD Serono, Sanofi, Janssen Oncology, PharmaMar, Daiichi Sankyo, Blueprint Medicines, Kolltan Pharmaceuticals, WIRB-Copernicus Group, ZIOPHARM Oncology, Polaris, Nektar, Genocea Biosciences, G1 Therapeutics, Caris Life Sciences, Adaptimmune, Eisai, Kyocera

Research Funding: Abbvie, Janssen Oncology

Patents, Royalties, & Other Intellectual Property: Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber and Novartis

No conflicts to report

No conflicts to report

Consulting or Advisory Role: AMAG Pharmaceuticals, ARIAD, Biodesix, Boehringer Ingelheim, Eisai, Gilead Sciences, Helsinn Therapeutics, Lilly, Roche/Genentech

Research Funding: Puma Biotechnology

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Merck, Astellas Pharma

No conflicts to report

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Merck, Lilly

Other Relationships: Breast Cancer Research Foundation

Honoraria: CMP Healthcare Oncology Publishing, The ASCO Post

Consulting or Advisory Role: CommGeniX, International Genetics, AlphaSights

Travel, Accommodations, Expenses: Hospital Association of PA, Bristol-Myers Squibb

Other Relationships: BP

Research Funding: Pfizer, Amgen, Bristol-Myers Squibb, Novartis

Consulting or Advisory Role: Boehringer Ingelheim, Foamix, Novartis, Novocure, Quintiles, AstraZeneca, Legacy Healthcare, Janssen Research & Development, Adgero Bio Pharmaceuticals

Research Funding: Berg Pharma, Bristol-Myers Squibb

No conflicts to report

No conflicts to report

Leadership: Cellworks, LifeLink

Consulting or Advisory Role: Integra

Consulting or Advisory Role: Magellan Health

Consulting or Advisory Role: Clovis Oncology, Array BioPharma, Incyte

Research Funding: Seattle Genetics, Janssen Oncology

Travel, Accommodations, Expenses: Clovis Oncology, Array BioPharma

Honoraria: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Consulting or Advisory Role: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Speakers' Bureau: Genentech/Roche, Amgen, Bayer/Onyx

Research Funding: Bayer/Onyx, Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, MedImmune

No conflicts to report

Consulting or Advisory Role: AbbVie, Aduro, Association of Community Cancer Centers, bioTheranostics, Boston Biomedical, Bristol-Myers Squibb, Eli Lilly, Foundation Medicine, Genentech, Genomic Health, Heron, Novartis, Taiho

No conflicts to report

Consulting or Advisory Role: Boehringer Ingelheim

Research Funding: Boehringer Ingelheim, AstraZeneca, Exelixis, Novartis, MedImmune, Merck, Genentech/Roche, Lilly, Bayer

Consulting or Advisory Role: Gerson Lehrman Group, Caris Life Sciences

Stock & Other Ownership Interests: AuraSense LLC, Nanosphere Inc.

Honoraria: Celgene, Pharmacyclics, Janssen Biotech, Valeant Pharmaceuticals International

Consulting or Advisory Role: Celgene, Genetech Health Practices Consulting, Seattle Genetics

Research Funding: Celgene, Lilly

Honoraria: Pfizer, Amgen, Bristol-Myers Squibb, Tesaro

Consulting or Advisory Role: Amgen, Bristol-Myers Squibb, Pfizer, Helsinn Therapeutics

Speakers' Bureau: Genentech/Roche

Research Funding: Helsinn Therapeutics

Honoraria: Genomic Health, Eisai, Genentech/Roche, Celgene

Consulting or Advisory Role: Genentech/Roche, Pfizer, Celgene, Eisai

Speakers' Bureau: Genomic Health, Eisai, Genentech/Roche, Celgene

Research Funding: Bayer

Travel, Accommodations, Expenses: Genomic Health, Genentech/Roche, Eisai, Celgene

Consulting or Advisory Role: 3M, BlueCross and BlueShield of Michigan, Amgen

Leadership: Syndax

Stock & Other Ownership Interests: Syndax

Honoraria: Symphogen

Consulting or Advisory Role: Symphogen, Coherus Biosciences, Radius Health, Peregrine Pharmaceuticals, Taiho Pharmaceutical

Research Funding: Genentech/Roche

Travel, Accommodations, Expenses: Nektar, Radius Health, Taiho Pharmaceutical

Employment: UpToDate

Patents, Royalties, & Other Intellectual Property: UpToDate, Royalties from Oxford Textbook of Cancer Communication, co-editor

Travel, Accommodations, Expenses: GEOMC, Inc. Seoul, Korea

No conflicts to report

Stock & Other Ownership Interests: GlaxoSmithKline, Novartis, Teva, Medtronic, Biogen, Bristol-Myers Squibb, Celgene, Pfizer, Immunogen, Isis Pharmaceuticals, Johnson & Johnson, Merck, United Health Group, Vertex, UCAN

Research Funding: Merck

Patents, Royalties, & Other Intellectual Property: Jones and Bartlett Publisher

No conflicts to report

Consulting or Advisory Role: Genomic Health

Travel, Accommodations, Expenses: TEVA, Tel Aviv

Consulting or Advisory Role: Merck, Pfizer

Honoraria: Bayer, Bristol-Myers Squibb, Fresenius Kabi, Roche, Pfizer

Consulting or Advisory Role: Bayer, Pfizer

Speakers' Bureau: Bayer, Daiichi Sankyo

Travel, Accommodations, Expenses: Pfizer

No conflicts to report

Honoraria: Roche, Novartis, Pfizer, MSD Oncology, Lilly

Research Funding: Roche

Travel, Accommodations, Expenses: Celgene, MSD Oncology, Roche, Novartis

Leadership: IBA - Ion Beam Applications

Consulting or Advisory Role: IBA

Travel, Accommodations, Expenses: IBA

Consulting or Advisory Role: AstraZeneca, Amgen, Boehringer Ingelheim

Speakers' Bureau: Roche

Stock & Other Ownership Interests: Agenus

Consulting or Advisory Role: Genomic Health, Atlantic Sante, Celtic Biotech, SCM Lamallen Toledano Bollet, Fleury Michon

Employment: The Chinese University of Hong Kong

Leadership: Sanomics Limited

Stock & Other Ownership Interests: Sanomics Limited, Cirina

Honoraria: AstraZeneca, Roche/Genentech, Lilly, Bristol-Myers Squibb, Boehringer Ingelheim, Novartis, Merck Sharp & Dohme, Pfizer

Consulting or Advisory Role: AstraZeneca, Roche/Genentech, Lilly, Merck Serono, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, Novartis, Clovis Oncology, Vertex, SFJ Pharmaceuticals Group, ACEA Biosciences, Merck Sharp & Dohme, geneDecode, Oncogenex, Celgene, Ignyta, Cirina

Research Funding: AstraZeneca, Boehringer Ingelheim, Pfizer, Novartis, SFJ Pharmaceuticals Group, Roche, Merck Sharp & Dohme, Clovis Oncology, Bristol-Myers Squibb, Taiho Pharmaceutical, Eisai

No conflicts to report

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Bristol-Myers Squibb, AstraZeneca, MSD Oncology

Speakers' Bureau: MSD Oncology, Bristol-Myers Squibb

Travel, Accommodations, Expenses: Bristol-Myers Squibb, Pfizer

Advertisement

Advertisement



Advertisement